PhRMA vs. CMS' GLOBE: The New Medicare Part B Drug Pricing Fight Jeff ByersandMichael S. Gerber October 30, 2026

https://www.healthaffairs.org/do/10.1377/hp20261029.616600/full/?utm_campaign=podcast&utm_medium=email&_hsenc=p2ANqtz--liXo5irL5DKoFxC2GUf0FRRew6teXuMmj36CfjTjTN020TOpg6gpO54p7ZktX2i-SOoP7CBgrSdkNr9Bev1mFTyEE1Q&_hsmi=446794715&utm_content=hatw&utm_source=hasu Can international reference pricing lower Medicare drug costs? Jeff Byers and Michael Gerber break down the finalized GLOBE model, the lawsuit challenging it, and the implications for drug pricing policy.